×
Predictors of the Development of Phobic Avoidance. PDF
$ 40.00
Predictors of the Development of Phobic Avoidance. PDF quantity
$ 40.00
×
The Pharmacologic Treatment of Bipolar DisorderEffective Agents in Treating Bipolar Depression PDF
$ 40.00
The Pharmacologic Treatment of Bipolar DisorderEffective Agents in Treating Bipolar Depression PDF quantity
$ 40.00
×
Movement Disorders Associated With the Serotonin Selective Reuptake Inhibitors PDF
$ 40.00
Movement Disorders Associated With the Serotonin Selective Reuptake Inhibitors PDF quantity
$ 40.00
×
Pimavanserin: A 2019 Clarification on the FDA Update PDF
$ 40.00
Pimavanserin: A 2019 Clarification on the FDA Update PDF quantity
$ 40.00
×
"We Cut and Drink Blood When We Have Sex. Do We Have a Problem?" A Case Report of Atypical Antipsychotic-Treated Paraphilia PDF
$ 40.00
"We Cut and Drink Blood When We Have Sex. Do We Have a Problem?" A Case Report of Atypical Antipsychotic-Treated Paraphilia PDF quantity
$ 40.00
×
A Double-Blind, Placebo-Controlled Study of Quetiapine and Lithium Monotherapy in Adults in the Acute Phase of Bipolar Depression (EMBOLDEN I) PDF
$ 40.00
A Double-Blind, Placebo-Controlled Study of Quetiapine and Lithium Monotherapy in Adults in the Acute Phase of Bipolar Depression (EMBOLDEN I) PDF quantity
$ 40.00
×
Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study PDF
$ 40.00
Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart